New Combination Drug Regimens Using Hypomethylating Agents in Treating Older Patients With New Diagnosis of Acute Myeloid Leukemia

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.